New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry
Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.
A federal appeals court in New York upheld his lifetime ban from the business.
More Stories
TikTok breached EU advertising transparency laws, commission says
Microsoft employee interrupts CEO’s keynote with pro-Palestinian protest
Sing when you’re winning: how karaoke in cars heralds the triumph of Chinese firms